May 25, 2018 5:03 PM ET


Company Overview of Intarcia Therapeutics, Inc.

Key Executives for Intarcia Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Kurt C. Graves 42 RelationshipsExecutive Chairman, CEO & President49
James M. Ahlers No RelationshipsCFO & VP of Finance & Operations53
Michelle Baron No RelationshipsChief Medical Officer and Vice President of Clinical Research--
Paul L. Feldman No RelationshipsHead of Discovery & Translational Medicine--
Seth Goldenberg No RelationshipsChief Design Officer--
View More Key Executives

Intarcia Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Kurt C. Graves 42 RelationshipsIntarcia Therapeutics, Inc.49
Bryan Eisman Roberts 120 RelationshipsCastlight Health, Inc.50
Gino Santini 69 RelationshipsAMAG Pharmaceuticals, Inc.60
Nancy Thornberry 22 RelationshipsKallyope Inc.--
Patrick Hugh Conway 25 RelationshipsBlue Cross and Blue Shield of North Carolina--
View All Board Members

Intarcia Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Intarcia Therapeutics, Inc. CEO Compensation
Industry Average


Sensorion Appoints Christine Petit as Chair of its Scientific Advisory Board
May 22, 2018 5:30 AM ET
Zelda Therapeutics Limited Announces Executive Changes
May 21, 2018 10:21 PM ET
Trevena, Inc. Appoints Mark A. Demitrack as Senior Vice President and Chief Medical Officer
May 21, 2018 9:13 PM ET
PDL BioPharma, Inc. Appoints Jill M. Jene, Ph.D. as Vice President, Business Development
May 21, 2018 1:06 PM ET
Deciphera Pharmaceuticals Elects Steven Hoerter to its Board of Director
May 21, 2018 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Intarcia Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at